FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Pitzer

Research Profile

Anatomy

Procedures

Living Beings

Chemicals & Drugs

Physiology

Disorders

Concepts & Ideas

Cell Count

Activities & Behaviors

Co-author Network

Publications

TOP 3
Jodi L McBride; Sergio R Ojeda; Mark R Pitzer; Ryan L Boudreau; Brett Dufour; Theodore Hobbs; Beverly L Davidson
Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease.
Caryl E Sortwell; William J Bowers; Scott E Counts; Mark R Pitzer; Matthew F Fleming; Susan McGuire; Kathleen A Maguire-Zeiss; Howard Federoff; Timothy J Collier
Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival.
Jodi L McBride; Shilpa Ramaswamy; Mehdi Gasmi; raymond bartus; Christopher D Herzog; Eugene Brandon; Lili Zhou; Mark R Pitzer; Elizabeth M Berry-Kravis; Jeffrey Kordower
Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Pitzer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Jodi L McBride; Sergio R Ojeda; Mark R Pitzer; Ryan L Boudreau; Brett Dufour; Theodore Hobbs; Beverly L Davidson
Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease.
Molecular therapy : the journal of the American Society of Gene Therapy 2011;19(12):2152-62.
2007: Caryl E Sortwell; William J Bowers; Scott E Counts; Mark R Pitzer; Matthew F Fleming; Susan McGuire; Kathleen A Maguire-Zeiss; Howard Federoff; Timothy J Collier
Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival.
Brain research 2007;1134(1):33-44.
2006: Jodi L McBride; Shilpa Ramaswamy; Mehdi Gasmi; raymond bartus; Christopher D Herzog; Eugene Brandon; Lili Zhou; Mark R Pitzer; Elizabeth M Berry-Kravis; Jeffrey Kordower
Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(24):9345-50.
2004: Caryl E Sortwell; Timothy J Collier; Maria D Camargo; Mark R Pitzer
An in vitro interval before transplantation of mesencephalic reaggregates does not compromise survival or functionality.
Experimental neurology 2004;187(1):58-64.
2004: Deanna M Marchionini; Timothy J Collier; Mark R Pitzer; Caryl E Sortwell
Reassessment of caspase inhibition to augment grafted dopamine neuron survival.
Cell transplantation 2004;13(3):273-82.
2003: M Holtmann; A E Meyer; Mark R Pitzer; M H Schmidt
Risperidone-induced marked elevation of serum creatine kinase in adolescence. A case report.
Pharmacopsychiatry 2003;36(6):317-8.
2003: Deanna M Marchionini; Timothy J Collier; Maria D Camargo; Susan McGuire; Mark R Pitzer; Caryl E Sortwell
Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease.
The Journal of comparative neurology 2003;464(2):172-9.
2003: Mark R Pitzer; Caryl E Sortwell; Brian F Daley; Susan McGuire; Deanna M Marchionini; Matthew Fleming; Timothy J Collier
Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells.
Experimental neurology 2003;182(2):435-45.
2001: Paul Carvey; ZD Ling; Caryl E Sortwell; Mark R Pitzer; Susan McGuire; Alexander Storch; Timothy J Collier
A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.
Experimental neurology 2001;171(1):98-108.
2001: Caryl E Sortwell; Maria D Camargo; Mark R Pitzer; S Gyawali; Timothy J Collier
Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval.
Experimental neurology 2001;169(1):23-9.
2000: Caryl E Sortwell; Brian F Daley; Mark R Pitzer; Susan McGuire; John R Sladek; Timothy J Collier
Oligodendrocyte-type 2 astrocyte-derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell death.
The Journal of comparative neurology 2000;426(1):143-53.
2000: Caryl E Sortwell; Mark R Pitzer; Timothy J Collier
Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival.
Experimental neurology 2000;165(2):268-77.
1997: Mark R Pitzer; Robert D. Wirtshafter
The distribution of reduced nicotinamide adenine dinucleotide phosphate-diaphorase in the leopard frog telencephalon and related projections.
Brain, behavior and evolution 1997;50(3):152-66.
1994: Robert D. Wirtshafter; Karen E Asin; Mark R Pitzer
Dopamine agonists and stress produce different patterns of Fos-like immunoreactivity in the lateral habenula.
Brain research 1994;633(1-2):21-6.
1993: Robert D. Wirtshafter; Thomas Stratford; Mark R Pitzer
Studies on the behavioral activation produced by stimulation of GABAB receptors in the median raphe nucleus.
Behavioural brain research 1993;59(1-2):83-93.